NY A03236 | 2025-2026 | General Assembly
Status
Spectrum: Partisan Bill (Democrat 3-0)
Status: Introduced on January 27 2025 - 25% progression
Action: 2025-01-27 - referred to health
Pending: Assembly Health Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 27 2025 - 25% progression
Action: 2025-01-27 - referred to health
Pending: Assembly Health Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.
Title
Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2025-01-27 | Assembly | referred to health |
Same As/Similar To
S01618 (Same As) 2025-01-21 - REPORTED AND COMMITTED TO FINANCE
